Literature DB >> 31247151

The Surprising Reintroduction of Primatene Mist in the United States.

S Christy Sadreameli1, Emily P Brigham2, Ajanta Patel3.   

Abstract

Entities:  

Year:  2019        PMID： 31247151      PMCID： PMC7051476          DOI： 10.1513/AnnalsATS.201902-164HP

Source DB:  PubMed          Journal:  Ann Am Thorac Soc        ISSN： 2325-6621


× No keyword cloud information.
  10 in total

1.  Safety of over-the-counter inhalers for asthma: report of the council on scientific affairs.

Authors:  B D Dickinson; R D Altman; S D Deitchman; H C Champion
Journal:  Chest       Date:  2000-08       Impact factor: 9.410

2.  Use of ozone-depleting substances; removal of essential-use designation (flunisolide, etc.). Final rule.

Authors: 
Journal:  Fed Regist       Date:  2010-04-14

3.  Epinephrine: a short history.

Authors:  Greer Arthur
Journal:  Lancet Respir Med       Date:  2015-05       Impact factor: 30.700

Review 4.  Asthma medications should be available for over-the-counter use: pro.

Authors:  Joe K Gerald; Michael E Wechsler; Fernando D Martinez
Journal:  Ann Am Thorac Soc       Date:  2014-07

5.  Quarterly assessment of short-acting beta(2)-adrenergic agonist use as a predictor of subsequent health care use for asthmatic patients in the United States.

Authors:  Harris S Silver; Christopher M Blanchette; Shital Kamble; Hans Petersen; Matthew Letter; David Meddis; Benjamin Gutierrez
Journal:  J Asthma       Date:  2010-08       Impact factor: 2.515

6.  Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma-Summary Report 2007.

Authors: 
Journal:  J Allergy Clin Immunol       Date:  2007-11       Impact factor: 10.793

7.  [Dose-effect of adrenaline nebulization in asthma: comparative study with salbutamol].

Authors:  S Elatrous; H Elidrissi; H Trabelsi; R Boujdaria; M Boussarsar; L Ouannes; K Bouzouita; S Nouira; M F Abroug
Journal:  Rev Pneumol Clin       Date:  1997

8.  Nonprescription racemic epinephrine for asthma.

Authors:  Pritish Mondal; Bhargava Kandala; Richard Ahrens; Sarah E Chesrown; Leslie Hendeles
Journal:  J Allergy Clin Immunol Pract       Date:  2014-04-18

9.  High use of health services in patients with suboptimal asthma drug regimens: a population-based assessment in British Columbia, Canada.

Authors:  Tingting Zhang; M Anne Smith; Pat G Camp; Bruce C Carleton
Journal:  Pharmacoepidemiol Drug Saf       Date:  2013-04-05       Impact factor: 2.890

10.  Short-acting β-agonist use and its ability to predict future asthma-related outcomes.

Authors:  Richard H Stanford; Manan B Shah; Anna O D'Souza; Amol D Dhamane; Michael Schatz
Journal:  Ann Allergy Asthma Immunol       Date:  2012-10-01       Impact factor: 6.347
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.